Godavari Biorefineries IPO Launches: Key Details and Risks
Godavari Biorefineries IPO: The initial public offering (IPO) of Godavari Biorefineries, a manufacturer of ethanol-based chemicals, started on Wednesday, October 23. This Rs. 555 crore book-built issue includes a fresh issue of 92 lakh shares and an offer for sale (OFS) of 65 lakh shares. The IPO will close for subscription on Friday, October 25, with shares priced between Rs. 334 and Rs. 352.
Use of Proceeds
From the total Rs. 555 crore raised, the company plans to generate Rs. 325 crore through the fresh issue of shares. This amount will be used to pay off certain outstanding debts and for general corporate purposes.
Important Dates
Share Allotment Finalization: Expected on Monday, October 28
Shares Credited to Demat Accounts: Tuesday, October 29
Refunds for Non-Allocated Shares: Also on Tuesday, October 29
Expected Listing Date: Wednesday, October 30, on BSE and NSE
Market Expectations
Current market reports indicate that the grey market premium (GMP) for Godavari Biorefineries shares is zero, suggesting that the stock might list flat.
Key Risks to Consider
Investors should be aware of several risks associated with this IPO, as outlined in the company’s Red Herring Prospectus (RHP):
Supplier Dependence
The company relies on a limited number of suppliers for key raw materials (excluding sugarcane). If it fails to secure these materials, manufacturing operations may suffer.
Cost of Materials
A significant portion of the company's expenses comes from materials consumed. Rising costs that cannot be offset could impact profitability.
Customer Concentration: Revenue comes from a few key customers and products. A decline in demand from these customers could adversely affect operations.
Legal Proceedings: There are ongoing legal issues involving the company and some of its promoters and directors.
Borrowing Risks: The company has unsecured borrowings that lenders can recall at any time.
Third-Party Manufacturing: The company depends on third-party manufacturers for its retail brand, Jivana. Any disruptions in their supply or failure to meet quality standards could impact business.
Seasonal Variability: The sugar, distillery, and cogeneration segments are affected by seasonal changes, which could negatively impact financial conditions and operations.
Government Policy Dependence: Revenue from ethanol sales relies on government policies related to the ethanol blended petrol program. Changes in these policies could adversely affect revenue.
Capital Intensity: The biochemicals industry is capital-intensive, requiring the company to seek additional financing for growth in the future.
Also read: Deepak Builders & Engineers IPO Sees Strong Interest from Investors
Foreign Currency Risks: Some revenues are in foreign currencies, exposing the company to foreign exchange risks.
.